pdufa.bio
HomeConferences › ESC

European Society of Cardiology Congress 2026

Updated ·next FDA decision on the calendar

Aug 28-31, 2026 · Munich, DE · Cardiology.

DatesAug 28-31, 2026
LocationMunich, DE
Therapeutic focusCardiology
Biotech presenters tracked0

Biotech presenters

TENXTenax Therapeutics Late-breaking · ConfirmedPh3 LEVEL - oral levosimendan (PH-HFpEF)

How ESC stocks have traded historically

Median share-price move around a presentation, measured across 1425 all tracked conference presentations in our study (2017-2026), because our study holds fewer than 12 ESC events on their own.
30 days before-0.03%  50% rose · n=1425
10 days before+0.63%  52% rose · n=1425
Presentation day-0.56%  44% rose · n=1425
5 days after-1.59%  39% rose · n=1425
10 days after-1.93%  40% rose · n=1425
Read the whole row, not just the first line: across this study stocks have drifted up into these meetings and down out of them, and the effect is largest in the smallest companies. Medians are shown because a handful of large moves pulls an average away from the typical case. This is a historical distribution for a cohort of companies, not a forecast for any single company, and not investment advice. Methodology and the full study.

FAQ

When is ESC 2026?
European Society of Cardiology Congress 2026 runs August 28-31, 2026 in Munich, DE. The date comes from the organiser's own announcement; check the organiser's site for the final programme.
Which biotech companies are presenting at ESC 2026?
From company filings and releases we have sourced 2 presenter commitments for this edition: CYTK, IONS. This is not the organiser's programme -- only presentations companies have themselves announced, each linked to its filing on the conferences page.
Why do medical conference dates matter for biotech stocks?
Trial results are often presented first at medical meetings, so a company's announced presentation is a dated, public catalyst. We publish a study of how biotech stocks have historically traded into conference presentations on the research page; it is historical measurement, not a prediction, and none of this is investment advice.